| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 119.38M | 119.38M | 100.49M | 81.10M | 70.78M | 58.71M |
| Gross Profit | 80.12M | 80.12M | 81.75M | 65.79M | 59.38M | 47.70M |
| EBITDA | 38.05M | 38.05M | 25.27M | 15.67M | 15.22M | 16.32M |
| Net Income | 20.20M | 20.20M | 11.53M | 6.58M | 9.51M | 11.12M |
Balance Sheet | ||||||
| Total Assets | 69.73M | 69.73M | 51.23M | 47.30M | 41.94M | 39.47M |
| Cash, Cash Equivalents and Short-Term Investments | 38.84M | 38.84M | 36.39M | 32.73M | 27.39M | 27.81M |
| Total Debt | 2.18M | 2.18M | 2.77M | 2.20M | 834.00K | 1.57M |
| Total Liabilities | 29.28M | 29.28M | 21.09M | 20.55M | 17.27M | 15.29M |
| Stockholders Equity | 40.45M | 40.45M | 30.14M | 26.75M | 24.66M | 24.18M |
Cash Flow | ||||||
| Free Cash Flow | 26.61M | 26.61M | 21.27M | 16.00M | 15.40M | 15.41M |
| Operating Cash Flow | 26.89M | 26.89M | 22.29M | 16.20M | 16.16M | 15.50M |
| Investing Cash Flow | -21.85M | -21.85M | -11.17M | -4.07M | -4.12M | -120.00K |
| Financing Cash Flow | -12.59M | -12.59M | -11.86M | -6.79M | -12.46M | -9.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | AU$339.67M | 18.26 | 32.31% | 4.00% | 10.61% | 23.34% | |
69 Neutral | AU$657.74M | 20.35 | 8.50% | 4.63% | 4.26% | 79.41% | |
68 Neutral | AU$1.16B | 26.66 | 5.73% | 4.92% | 21.81% | -43.93% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | AU$522.48M | 25.39 | 58.10% | 2.70% | 18.80% | 74.51% | |
45 Neutral | AU$1.93B | 46.56 | 8.97% | 1.85% | 35.30% | 44.24% |
Australian Ethical Investment Ltd has notified the ASX that it has ceased to be a substantial holder in Australian Clinical Labs Limited, lodging a formal notice confirming its relevant interest in the pathology company’s voting securities fell below the substantial holding threshold on 15 January 2026. The change, documented in a statutory Form 605 and involving State Street Australia Ltd as custodian, signals a reduction in Australian Ethical’s exposure to Australian Clinical Labs and may indicate a portfolio rebalancing or strategic shift in its ethical investment holdings, with potential implications for the shareholder base and trading liquidity of Australian Clinical Labs shares.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$6.00 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.
Australian Ethical Investment reported funds under management of $14.08 billion as at 31 December 2025, a 1% decline over the quarter as positive retail and wholesale inflows, particularly in superannuation, were offset by negative investment performance and the redemption of a low‑margin $0.25 billion institutional banking mandate following Australian Unity Bank’s sale to Bank Australia. The company highlighted stronger superannuation member growth driven by enhanced digital marketing and the completed transition of its retail super fund administration to GROW, which is already delivering cost efficiencies, alongside ongoing implementation of the Charles River investment platform to build an institutional‑grade, scalable operating base. Management expects that lost mandate revenue will be neutralised by platform simplification and cost savings, is building a pipeline in middle‑market channels, has filled key executive roles including a new COO and CRO, and continues to strengthen its positioning in ethical investing, underlined by recent ESG super and pension product awards.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$6.00 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.
Australian Ethical Investment Ltd has notified the ASX that it has ceased to be a substantial holder in Shriro Holdings Limited, following changes in its relevant interests in Shriro’s voting securities as at 29 December 2025. The move, formalised via a regulatory notice, indicates that Australian Ethical’s shareholding in Shriro has fallen below the substantial holding threshold, potentially reflecting portfolio rebalancing or a shift in exposure to the stock, and may modestly alter Shriro’s register composition and the influence of institutional ethical investors on the company.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.
Australian Ethical Investment Ltd has released its 2026 reporting calendar, outlining key dates for quarterly funds under management and flows updates, half-year and full-year financial results, dividend ex-dates, record and payment dates, director nomination deadlines, and its Annual General Meeting. The schedule provides stakeholders with clear visibility on the company’s financial reporting and governance milestones for 2026, supporting planning for investors, analysts and shareholders, although the company notes that the dates may be adjusted for operational reasons.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.
Australian Ethical Investment Ltd (AEF) has announced that the Australian Prudential Regulation Authority (APRA) has imposed additional license conditions on its subsidiary, Australian Ethical Superannuation Pty Ltd (AES). These conditions require AES to appoint an independent expert to review related-party arrangements with AEF. AEF does not believe these conditions will materially affect the price or value of its securities, and the company remains confident in its governance and operational strategies. The review is seen as an opportunity to strengthen AES’s decision-making processes without financial penalties, and AEF anticipates no negative impact on members’ retirement savings.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.
Australian Ethical Investment Ltd has released its Corporate Governance Statement, which aligns with the ASX Corporate Governance Council Principles and Recommendations. This announcement underscores the company’s dedication to maintaining high standards of corporate governance, potentially enhancing its reputation and trust among stakeholders.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.
Australian Ethical Superannuation Pty Ltd, a trustee of Australian Ethical Investment Ltd, has received additional license conditions from APRA, requiring an independent review of related-party arrangements. Despite these conditions, the company assures that members’ retirement savings remain secure, and the fund has achieved strong returns in the past year. The company has proactively enhanced its governance processes and remains committed to ethical investing and members’ financial interests.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$6.50 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.
Australian Ethical Investment Limited has announced the issuance of 410,304 ordinary fully paid shares to the Trustee of the Australian Ethical Investment Employee Share Plan. These shares are intended to benefit employees under the plan, with an issue price based on the 20-day volume-weighted average price of the company’s shares. This move is part of the company’s broader strategy to incentivize and retain talent, potentially impacting its operational dynamics and stakeholder relations positively.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$7.50 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.
Australian Ethical Investment Ltd held its Annual General Meeting, where key resolutions were passed, including the re-election and election of directors and the approval of long-term performance share rights for the CEO. These decisions reflect the company’s strategic focus on leadership stability and incentivizing executive performance, potentially impacting its market positioning and stakeholder confidence positively.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$7.50 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.
Australian Ethical Investment Ltd, a leading ethical investment manager, continues to focus on providing value-aligned investment products. With over $14 billion in funds under management, the company is well-positioned in the ethical investment space, emphasizing long-term, risk-adjusted returns guided by its Ethical Charter.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$7.50 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.
Australian Ethical Investment Ltd, a leading ethical investment manager in Australia, emphasizes its commitment to providing value-aligned investment products and maintaining significant funds under management. The company’s operations are deeply rooted in its ethical charter, which influences its culture and vision, positioning it strongly in the ethical investment market.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$7.50 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.
Australian Ethical Investment Ltd has increased its substantial holding in Eroad Limited, as disclosed in a recent notice. The company’s stake in Eroad Limited has risen from 12.90% to 15.02% following multiple on-market transactions, indicating a strategic move to strengthen its position in the company.
The most recent analyst rating on (AU:AEF) stock is a Hold with a A$7.50 price target. To see the full list of analyst forecasts on Australian Ethical Investment Ltd stock, see the AU:AEF Stock Forecast page.